HEDS Home Page

Welcome to the Health Economics and Decision Science Section of ScHARR

The Section

The purpose of HEDS is to promote excellence in health care resource allocation decisions. HEDS makes major contributions in areas that include the valuation of health, the analysis of health policy, welfare and equity, technology appraisal,evidence synthesis, econometrics and information sciences.

We also lead several national research collaborations, supervise PhD students, contribute to Masters programmes, deliver external training courses and provide input to national committees. Find out more about our activities in the most recent issue of our newsletter.

Latest publications

Atienzo, E. E., Kaltenthaler, E. and Baxter, S. K. ‘Barriers and Facilitators to the Implementation of Interventions to Prevent Youth Violence in Latin America: A Systematic Review and Qualitative Evidence Synthesis’, Trauma, Violence, & Abuse. Aug, 2016.

Rafia, R., Scope, A., Harnan, S., Stevens, J. W., Stevenson, M. and Lobo, A. ‘Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal’, PharmacoEconomics. Aug, 2016.

De Vocht, F., Heron, J., Campbell, R., Egan, M., Mooney, J. D., Angus, C., Brennan, A. and Hickman, M. ‘Testing the impact of local alcohol licencing policies on reported crime rates in England’, Journal of Epidemiology and Community Health. Aug, 2016.

Consultancy, Innovation & Knowledge Transfer

HEDS delivers a vibrant portfolio of consultancy-funded research to the pharmaceutical and medical devices sector and the NHS. It utilises our broad range of skills and is complemented by tailored training courses covering a full range of research methods, as well as policy issues such as pricing and reimbursement. If you want to discuss any opportunities, please contact the ScHARR IKT team.

Latest project news

Cancer biomarkers for screening 
Lead researcher, Dr Lesley Uttley, from ScHARR, said: “Our data mining approach allowed us to take in all relevant research findings from the five-year period, which meant we could map the full range of potential blood-based biomarkers that are particularly relevant for early detection of cancer.” More information

NICE guidelines on harmful sexual behaviour in children and young people
ScHARR have been involved in two systematic reviews of evidence that informed new NICE guidelines on harmful sexual behaviour in children and young people. Fiona Campbell, Anthea Sutton and Andrew Booth were part of a team. Website

Section Director

Professor Simon Dixon

Deputy Section Director

Dr Eva Kaltenthaler

HEDS blog

The best way to keep up with our work and our impact on policy is to read the HEDS Blog. With over 70,000 hits from over 110 different countries recent blog posts also feature on Twitter: